Men's Health News

RSS

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announced today that data from the pivotal Phase III study with GARDASIL in males were published in the February 3 issue of the New England Journal of Medicine.

3 Feb 2011

Four-gene/protein signature more accurately predicts metastatic prostate cancer

Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, researchers at Dana-Farber Cancer Institute report in a study published online today by the journal Nature. The discovery lays the groundwork for the first gene-based test for determining whether a man's prostate cancer is likely to remain dormant within the prostate gland, or spread lethally to other parts of the body.

3 Feb 2011

New study examines role of later acquisition of hepatitis C in HIV patients

Hepatitis C is a leading cause of illness and death for individuals infected with both HIV and hepatitis C. Recent reports from around the world demonstrate that hepatitis C is emerging as a sexually transmitted infection among HIV-infected men who do not inject drugs. However, many HIV-infected men do not receive continued screening for hepatitis C throughout their HIV care.

2 Feb 2011

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of Inovio's SynCon DNA vaccine for prostate cancer targeting two antigens.

2 Feb 2011

“Enjoy your food but eat less”: Latest Dietary guidelines

New federal dietary guidelines, released Monday by the U.S. Department of Agriculture and the Department of Health and Human Services lays down some new rules in healthy eating that include consuming less empty calories, less salt and at least half a plate full of fruits and vegetables a day.

1 Feb 2011

New study: FUS protein appears to inhibit growth of prostate cancer cells in lab

Cancer researchers have discovered an important protein, produced naturally inside cells, that appears to suppress the growth of prostate cancer cells in the laboratory. The findings, published tomorrow in the journal Cancer Research, offer promising leads for research towards new treatments.

31 Jan 2011

North Shore-LIJ seeks patients with early-stage prostate cancer to participate in Phase I study

The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with early-stage prostate cancer to participate in a Phase I Research study.

29 Jan 2011

Men more distressed by type of infidelity that threatens paternity of offspring

Men are more than twice as likely to continue dating a girlfriend who has cheated on them with another woman than one who has cheated with another man, according to new research from a University of Texas at Austin psychologist.

28 Jan 2011

Lipocine files new patent applications in support of oral testosterone product for hypogonadism

Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.

28 Jan 2011

XYTOS shares cancer patient treatment results

XYTOS Shares Patient Results.

28 Jan 2011

FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk

GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).

27 Jan 2011

Monogamy unpopular among young people: Study

Jocelyn Warren of Oregon State University, commenting on the study said, “Couples have a hard time talking about these sorts of issues, and I would imagine for young people it’s even more difficult… Monogamy comes up quite a bit as a way to protect against sexually transmitted diseases.

23 Jan 2011

Australia’s Healthy Weight Week

The Dietitians Association of Australia (DAA) has launched Australia’s Healthy Weight Week (AHWW) on Sunday in an attempt to make people choose a healthier lifestyle of eating better and exercising more.

23 Jan 2011

Researchers believe driver mutations promote development, growth of prostate cancer

Prostate cancer is known to occur typically in older men. Yet some patients are younger than 50 years at the time of diagnosis. Scientists assume that these cases might be the key to understanding the biology of this disease. Early prostate cancer might be a subtype which is characterized by a relatively small number of genetic modifications.

21 Jan 2011

New study reveals illicit HGH use among young American male weightlifters

A new study published in The American Journal on Addictions reveals that illicit use of HGH has become common among young American male weightlifters.

21 Jan 2011

Semen allergy to one's own

According to a study from Dutch researchers, some men are allergic to their own semen, developing a mysterious flu-like illness after they have an ejaculation. The condition, known as post-orgasmic illness syndrome or POIS, has been documented since 2002. It manifests as feverishness, runny nose, extreme fatigue and burning eyes, which can last for up to a week.

20 Jan 2011

Study: Vitamin E supplementation may extend life-span of restricted groups of men

Depending on the level of smoking and dietary vitamin C intake, vitamin E supplementation may extend the life-span of restricted groups of men, according to a study published in the Age and Ageing.

20 Jan 2011

New data on role of miR-34 tumor suppressor in preventing cancer stem cell development

Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.

18 Jan 2011

AMS introduces STEP toolkit to help men with ED and SUI

American Medical Systems, a leading provider of world-class devices and therapies for male and female pelvic health, today announced the launch of its Solutions to Educate Patients Program in Europe.

18 Jan 2011

Study finds miRNAs inhibits prostate cancer metastasis

A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells. A research team led by scientists at The University of Texas MD Anderson Cancer Center reported today in an advance online publication at Nature Medicine.

18 Jan 2011

Men's Health News

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Four-gene/protein signature more accurately predicts metastatic prostate cancer

New study examines role of later acquisition of hepatitis C in HIV patients

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

“Enjoy your food but eat less”: Latest Dietary guidelines

New study: FUS protein appears to inhibit growth of prostate cancer cells in lab

North Shore-LIJ seeks patients with early-stage prostate cancer to participate in Phase I study

Men more distressed by type of infidelity that threatens paternity of offspring

Lipocine files new patent applications in support of oral testosterone product for hypogonadism

XYTOS shares cancer patient treatment results

FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk

Monogamy unpopular among young people: Study

Australia’s Healthy Weight Week

Researchers believe driver mutations promote development, growth of prostate cancer

New study reveals illicit HGH use among young American male weightlifters

Semen allergy to one's own

Study: Vitamin E supplementation may extend life-span of restricted groups of men

New data on role of miR-34 tumor suppressor in preventing cancer stem cell development

AMS introduces STEP toolkit to help men with ED and SUI

Study finds miRNAs inhibits prostate cancer metastasis

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News